Malecare has just started a new petition asking that the Obama administration to: Light The White House Blue on Men's Health Night, November 21, in order to raise Prostate and Testicular cancer awareness. If we are able to get 5,000 signatures by October 22, 2011 we will get a response back from the Obama Administration. [...]
On September 15, the Senate Committee on Appropriations approved their FY12 report by a vote of 30-0. Included in the report was their recommendations for the Department of Defense Research Programs. […]
Light a Blue Bulb for Prostate Cancer Awareness Month, September 2011. This year, let’s take prostate cancer awareness building into our own hands. Light a Blue Bulb every night (or, for a few nights) during September. […]
The United States Veterans Administration (VA) has announced that, like those who served in Vietnam, veterans who served in Thailand maybe be entitled to VA benefits. Those who had served at one of the military bases in Thailand listed in the below URL and the locations at those bases identified, and experiencing any of the [...]
There is some good news; the New York State Legislature has passed the Oral Chemotherapy Equity Bill. However, before this bill can become law we have to have Governor Cuomo sign it, we need all of our New York Residents to contact the governor and ask that he signs it. […]
My recent Letter to the Editor of the New York Times in response to the Op-Ed piece decrying the cost of cancer treatments: Your recent editorial about the high cost of cancer drugs missed a number of very significant points which must be considered. Yes, newly developed cancer drugs are expensive, but when treatments like [...]
We dodged a bullet… for now! I’m pleased to report that the House just approved the FY12 DoD Appropriations Bill by a vote of 331-83. No amendments were offered to reduce or eliminate CDMRP (the Department of Defense Medical Research Program) funding. At this time we have managed to maintain the funding for the Prostate [...]
Yesterday there was an amendment passed on the House floor to restore the Prostate Cancer Research Program's 2012 funding to $80 million. The Department of Defense (DoD) Appropriations Bill (H.R. 2219) originally was slated to allocate only $64 million to the Prostate Cancer Research Program (PCRP), a 20% reduction from last year’s funding. Restoring these [...]
Darryl, the Malecare Executive Director, posted an organizational response to yesterday's New York Times Article on the newly approved advanced prostate cancer drugs and their economic impact. I thought that I would share his insightful post with everyone. "We can easily price commodities and drugs to whatever the market will bare, but how do we [...]
Today’s New York Times carried a front page article about the high cost of the new prostate cancer treatments. This article seems to be the talk of the town and the talk (based on the comments that have been entered on-line) has been anything but positive. Unfortunately, many of the comments have made with the [...]
